Edwards Lifesciences Consolidated Income Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 109.94  1.42  1.31%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Consolidated Income of Edwards Lifesciences Corporation with missing and latest data points interpolated. The portion of profit or loss for the period, net of income taxes, which is attributable to the consolidated entity, before the deduction of Net Income Available to Non-controlling Interests.
Consolidated Income  10 Years Trend  
Increasing
Slightly volatile
 Consolidated Income 
      Timeline 

Edwards Lifesciences Consolidated Income Over Time

2015-12-31  494,900,000 
2016-12-31  569,500,000 
2017-12-31  560,210,526 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  335,884,211
Coefficient Of Variation  70.06
Mean Deviation  190,898,246
Median  291,500,000
Standard Deviation  235,310,201
Range  822,500,000
R Value  0.88
R Squared  0.78
Significance  0.00015601
Slope  57,469,636

Currently Trending

S   
 NYQ 
Purchased over 400 shares of
a day ago ago
Traded for 7.12
GM   
 NYQ 
Purchased over 60 shares of
a day ago ago
Traded for 45.88
MSFT   
 NMS 
Purchased over 30 shares of
a day ago ago
Traded for 77.49